Carestream Health received FDA clearance for use of its Vue Motion image view for clinical X-ray reading on mobile devices.
The approval covers reading - not just viewing - on iPhone 4s, iPad 2, Galaxy Note and Galaxy S III mobile devices, the company announced.
“Diagnostic review of X-ray images with mobile devices can expedite patient treatment decisions and enable better collaboration, which can ultimately help enhance patient care,” Neville Skudowitz, Carestream’s global product director for healthcare information solutions, said in a statement.
Carestream recommends that during diagnostic image review, radiology professions frequently and concurrently use Vue Motion viewing tools, such as zoom, pan, and window level adjustments. This will help maximize image contrast and detail sharpness of each image displayed using Vue Motion on portable and mobile devices, according to the company.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.